Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.750
+0.060 (1.63%)
Jul 3, 2026, 2:48 PM CET
Scandinavian ChemoTech AB Market Cap
Scandinavian ChemoTech AB has a market cap or net worth of 95.45 million as of July 2, 2026. Its market cap has increased by 121.62% in one year.
Market Cap
95.45M
Enterprise Value
94.00M
Revenue
12.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.75
Market Cap Chart
Since December 6, 2016, Scandinavian ChemoTech AB's market cap has increased from 63.83M to 95.45M, an increase of 49.55%. That is a compound annual growth rate of 4.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 95.45M | -18.55% |
| Dec 30, 2025 | 117.19M | 180.45% |
| Dec 30, 2024 | 41.79M | -4.97% |
| Dec 29, 2023 | 43.97M | -27.52% |
| Dec 30, 2022 | 60.67M | -63.03% |
| Dec 30, 2021 | 164.08M | 100.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 120.94M |
| NextCell Pharma AB | 120.07M |
| Alligator Bioscience AB | 115.32M |
| Ascelia Pharma AB | 107.90M |
| Biovica International AB | 105.09M |
| OncoZenge AB | 101.43M |
| Spago Nanomedical AB | 93.41M |
| Annexin Pharmaceuticals AB | 91.77M |